Table 1 Characteristics of studies included in systematic review of tobacco use prevalence in Iranian cancer patients
From: Prevalence of tobacco use among cancer patients in Iran: a systematic review and meta-analysis
| Â | Type of consumption | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | Study design | Cancer type | Data collection method | Study province | Study period | Smokers (total patients) | Males (smokers) | Females (smokers) | Cigarette (N) | Naas (N) | Waterpipe (N) | Pipe (N) | Other (N) |
Abdolahinia 2021 [30] | Case–control | Bladder | Interview | Kerman | 2020 | 72 (100) | - | - | 72 | - | 3 | - | - |
Ahmadi 2012 [31] | Cross-sectional | Bladder | Questionnaire | Mazandaran | 2010–2011 | 52 (108) | - | - | - | - | - | - | - |
Akbari 2015 [32] | Case–control | Bladder | Questionnaire | Shiraz | 2012–2013 | 102 (198) | - | - | - | - | - | - | - |
Alipour fayez 2020 [39] | Cross-sectional | Lung | Questionnaire | Tehran | 2016–2017 | 15 (31) | - | - | 15 | - | - | - | - |
Aminisani 2016 [40] | Cross-sectional | Crc | Questionnaire | Mazandaran | 2007–2013 | 23 (157) | 97 (21) | 60 (2) | - | - | - | - | 23 |
Andishe-tadbir 2010 [41] | Cross-sectional | Hnscc | Cancer registry | Fars | 2000—2007 | 66 (148) | - | - | 44 | - | 20 | - | 2 |
Azimi 2018 [42] | Case–control | Hnscc | Questionnaire | Tehran | 2016–2017 | 43 (148) | - | - | 30 | - | - | - | 13 |
Hadji 2021 [36] | Case–control | Multiplea | Questionnaire | 10 providences | 2014–2020 | 2064 (6598) | - | - | 1697 | 56 | 300 | 11 | - |
Hosseini 2022 [38] | Case–control | Lung | Interview | 10 provinces | 2016—2020 | 409 (658) | 501 (398) | 157 (11) | 409 | - | 76 | - | 253 |
Khademi 2012 [43] | Cross-sectional | Upper gi | Questionnaire | Tehran | 2002–2009 | 31 (87) | - | - | 31 | - | - | - | - |
Khoshbaten 2010 [44] | Cross-sectional | Esophageal | Questionnaire | Tehran | - | 22 (100) | - | - | - | - | - | - | - |
Mafi 2012 [45] | Cross-sectional | Hnscc | Questionnaire | Tehran | 1995- 2010 | 185 (262) | 219 (177) | 43 (8) | 185 | - | - | - | - |
Mahouri 2007 [46] | Case–control | Breast | Questionnaire | Hormozgan | 2000–2002 | 67 (168) | - | - | - | - | - | - | - |
Mashhadi 2011 [47] | Cross-sectional | Esophageal | Questionnaire | Sistan-baluchestan | 2005–2010 | 143 (175) | - | - | - | - | - | - | - |
Masjedi 2013 [48] | Case–control | Lung | Questionnaire | Tehran | 2002–2005 | 199 (242) | 178 (161) | 64 (38) | 199 | - | - | - | - |
Moghadam 2021 [33] | Cohort | Gastric | Questionnaire | Kerman | 2001–2016 | 91 (339) | - | - | 91 | - | - | - | - |
Mohebbi 2020 [49] | Case–control | Hnscc | Questionnaire | 10 provinces | 2016 -2019 | 432 (663) | - | - | 371 | - | 61 | - | - |
Momayez 2021 [50] | Case–control | Pancreatic | Questionnaire | Tehran | 2012 -2018 | 113 (470) | 284 (104) | 186 (9) | 113 | - | - | - | - |
Momtahen 2009 [37] | Cross-sectional | Multipleb | Questionnaire | Tehran | 1995- 2005 | 45 (450) | - | - | - | - | - | - | - |
Motovali-bashi 2012 [51] | Cross-sectional | Lung | Interview | Tehran | 2009–2011 | 28 (65) | - | - | - | - | - | - | - |
Naghibzadeh 2016 [52] | Case–control | Crc | Interview | Kerman | 2014 | 51 (175) | - | - | 51 | - | - | - | - |
Nikbakht 2015 [53] | Cross-sectional | Crc | Questionnaire | Mazandaran | 2007–2012 | 53 (120) | 75 (51) | 45 (2) | 34 | - | 19 | - | - |
Pournaghi 2018 [54] | Case–control | Esophageal | Interview | North khorasan | 2013–2015 | 24 (96) | - | - | - | - | - | - | - |
Rafati 2019 [34] | Cohort | Breast | Questionnaire | Kerman | 2000–2015 | 53 (140) | - | - | - | - | - | - | - |
Sadjadi 2013 [55] | Cohort | Gastric | Questionnaire | Ardabil | - | 62 (129) | - | - | - | - | - | - | - |
Saedi 2009 [56] | Cross-sectional | Esophageal | Interview | Tehran | 1997–2007 | 400 (453) | 410 (361) | 43 (39) | - | - | - | - | - |
Salehi 2011 [57] | Cross-sectional | Bladder | Cancer registry | Fars | 2007- 2009 | 109 (216) | - | - | 85 | - | 24 | - | - |
Samadi 2007 [35] | Cohort | Upper gi | Interview | Ardabil | 2000–2004 | 135 (352) | - | - | - | - | - | - | - |
Sheikh 2020 [58] | Cohort | Multiplec | Interview | Golestan | 2004–2019 | 472 (1833) | - | - | - | - | - | - | - |
Shivappa 2015 [59] | Case–control | Esophageal | Interview | Kurdistan | - | 17 (47) | - | - | - | - | - | - | - |
Simonian 2018 [60] | Case–control | Crc | Interview | Isfahan | 2014 -2015 | 37 (187) | - | - | - | - | - | - | - |
Tabei 2006 [61] | Cross-sectional | Gastric | Interview | Fars | 2003 | 90 (177) | - | - | - | - | - | - | - |
Tarrahi 2009 [62] | Cohort | Lung | Interview | Southern iran | 2002–2007 | 160 (238) | - | - | - | - | - | - | - |
Vazirinezhad 2020 [63] | Case–control | Gi | Interview | Kerman | 2018 | 25 (95) | - | - | - | - | - | - | - |